$80.94
-4.33-5.08%
Last update: Oct 30, 4:00 PM
LeMaitre Vascular Inc
LMATNASDAQ
LeMaitre Vascular (LMAT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
LeMaitre Vascular (LMAT) last issued guidance on August 4, 2026 for Q4 2026. The company guided earnings per share in the range of $0.75 - $0.81, compared to a consensus EPS estimate of $0.79. LeMaitre Vascular also guided revenue in the range of $71.1M - $73.1M for the period.
Compared to prior guidance, LeMaitre Vascular raised its revenue forecast from a prior range of $66.3M - $68.3M.
LeMaitre Vascular has issued 32 guidance updates between February 23, 2023 and August 4, 2026. During this period, the company raised its outlook 18 times and lowered it 13 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.81 | $0.66 | $0.67 | $0.57 |
| Actual | $0.74 | $0.68 | $0.68 | $0.75 |
| Surprise | -8.64% | +3.03% | +1.49% | +31.6% |
| Revenue | ||||
| Estimate | $71.5M | $66.7M | $62.9M | $62.3M |
| Actual | $70.4M | $66.6M | $64.5M | $61.0M |
| Surprise | -1.60% | -0.18% | +2.48% | -1.94% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.69 | $0.78 | $0.74 | $0.83 |
| Revenue | ||||
| Consensus | $67.4M | $72.2M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $0.74 | $0.81 | -8.64 % |
| Q1 | May 5, 2026 | $0.68 | $0.66 | 3.03 % |
| Q4 | Feb 25, 2026 | $0.68 | $0.67 | 1.49 % |
| Q3 | Nov 6, 2025 | $0.75 | $0.57 | 31.6 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $70.38M | $71.53M | -1.60 % |
| Q1 | May 5, 2026 | $66.55M | $66.67M | -0.18 % |
| Q4 | Feb 25, 2026 | $64.45M | $62.89M | 2.48 % |
| Q3 | Nov 6, 2025 | $61.05M | $62.26M | -1.94 % |
